HOME

NEWS

CHARITIES

VOLUNTEER

ACTION CENTER

ADD CHARITY

CONTACT

SUPPORT

World Environment Community Health Animals Celebrity Submit A Site Find A Charity
Cambridge co-hosts £250m dementia research hub as scientists find possible neurodegeneration treatment

By Tony Quested, businessweekly.co.uk

63 days ago   Article ID# 4132513
Original URL

 

Alzheimer’s Society

CAMBRIDGE, U K (businessweekly.co.uk) - Cambridge scientists believe they have identified a potential means to slow the progress of Alzheimer’s disease and other dementias.

Their breakthrough coincides with the announcement of a new £250 million UK Dementia Research Institute to be part-based in the world-class science and technology cluster.

Professor Giovanna Mallucci, who led the Leicester-based research team and is now anchored at the University of Cambridge, is one of the five associate directors of the new UK Dementia Research Institute.

Her team, which had earlier identified a major pathway that leads to brain cell death in mice, have now found two repurposed drugs that block the pathway and prevent neurodegeneration. The drugs caused minimal side effects in the mice and one is already licensed for use in humans so is ready for clinical trials.

“We could know in 2-3 years whether this approach can slow down disease progression, which would be a very exciting first step in treating Alzheimer’s disease and other dementias,” she said.

The research was funded by the MRC and Professor Mallucci was also backed by a grant from Alzheimer’s Society and Alzheimer’s Drug Discovery Foundation.

The drugs they identified that restored protein production rates in mice were trazodone hydrochloride, a licensed antidepressant, and dibenzoylmethane, a compound being trialled as an anti-cancer drug.

Both drugs prevented the emergence of signs of brain cell damage in most of the prion-diseased mice and restored memory in the FTD mice. In both mouse models, the drugs reduced brain shrinkage which is a feature of neurodegenerative disease.

Professor Mallucci said: “We know that trazodone is safe to use in humans, so a clinical trial is now possible to test whether the protective effects of the drug we see on brain cells in mice with neurodegeneration also applies to people in the early stages of Alzheimer’s disease and other dementias.

“We could know in 2-3 years whether this approach can slow down disease progression, which would be a very exciting first step in treating these disorders. Interestingly, trazodone has been used to treat the symptoms of patients in later stages of dementia, so we know it is safe for this group. We now need to find out whether giving the drug to patients at an early stage could help arrest or slow down the disease through its effects on this pathway.”

The breakthrough coincides with the the University of Cambridge being unveiled as one of the centres that will form the UK Dementia Research Institute (UK DRI) alongside Cardiff University, the University of Edinburgh, Imperial College London and King’s College London.

The UK DRI is a joint £250 million investment into dementia research led by the Medical Research Council alongside founding charity partners Alzheimer’s Society and Alzheimer’s Research UK.

Established in response to the Government’s 2020 Challenge on Dementia, the DRI’s mission is to find new ways to diagnose, treat and prevent and care for people with dementias – a group of neurodegenerative disorders which include Alzheimer’s, Parkinson’s and Huntington’s disease.

Each centre will be led by an associate director and up to four programme leaders who will lead the centre’s foundation programmes. The centres have been awarded a total of 20 professorships and seven fellowships in the foundation phase, to build momentum in the institute.

The centres have a biomedical focus, and care research will also be integrated into the institute next year.

The Cambridge centre will be led by Professor Mallucci, who added: “We are very excited about the opportunity for Cambridge to be part of the UK DRI. Our centre on the Cambridge Biomedical Campus will focus on interdisciplinary science, building on our University’s strengths across research areas from chemistry and biophysics through to cell biology of neurodegeneration.”

Science Minister Jo Johnson added: “Dementia affects millions of people around the world but through greater understanding we can make significant steps forward to improve lives. Today’s announcement of the institute’s centre locations demonstrates the UK’s existing wealth of knowledge and research expertise, and the leadership role we can take in developing new treatments to tackle this disease.”

Copyright 2017 businessweekly.co.uk   (Copyright Terms)
Updated 63 days ago   Article ID# 4132513

Alzheimer’s Society    Visit Website

More News

Support services tackle the stigma of dementia

18 days ago From cardigan-today.co.uk 

WALES, U K - ...

England legends and 1966 World Cup heroes Sir Geoff Hurst and Gordon Banks launch United Against Dementia campaign

57 days ago From mirror.co.uk 

LONDON, U K - ...

Alzheimer’s charity recruits volunteers to combat loneliness

62 days ago From sundaypost.com 

DUNDEE, U K - ...

David Baddiel to be ambassador for Alzheimer's charity after telling of dad's battle with dementia

86 days ago From mirror.co.uk 

LONDON, U K - ...

Charity launches dementia advice service at Skipton surgery

105 days ago From cravenherald.co.uk 

SKIPTON, U K - ...

Go to page:   1    2  3  Next >> 

<< Return To Health News

Action Center

Warming temperatures threaten sea turtles

Action: Climate Change

The study by Dr Jacques-Olivier Laloë of the University’s College of Science and published in the Global Change Biology journ ...

Interpol says there really are dark web rhino horn traffickers

Action: Wildlife Conservation

The dark web is home to several lingering myths: so-called red rooms where visitors can watch gruesome murders; sites offerin ...

New highway brings deforestation to two Colombian national parks

Action: Stop Deforestation

Planned since the 1950s, the Marginal de la Selva is a $1 billion highway project that would create a paved land passage thro ...

Stop coal mining assault on this roadless forest

Action: Stop Pollution

President Trump has been clear since day one that he’s turning over the nation’s public lands and environment to King Coal an ...

Thousands of dolphins killed in fishing nets used in EU waters

Action: Save Our Oceans

New data from French scientists reveals that unprecedented numbers of common dolphins have died and stranded this year as a r ...

View All Actions >>

 

 

Charities

News

Follow Us

Support

Find A Charity

Action Center

World

Community

Facebook

Twitter Support

Contact

Volunteer

Add A Site

Environment

Animals

Google+

Privacy Policy

Copyright

 

 

Health

Celebrity

Terms of Service

Copyright © The Charity Vault All rights reserved.